Related Experiment Video
Updated: May 4, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic
Sachin S Goel1, Shikhar Agarwal, E Murat Tuzcu
1Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, J2-3, 9500 Euclid Ave, Cleveland, OH 44195, USA. kapadis@ccf.org
Insights
Percutaneous coronary intervention (PCI) in patients with severe aortic stenosis (AS) shows similar short-term mortality to those without AS. However, patients with low ejection fraction or high surgical risk scores face increased 30-day mortality after PCI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Management of coronary artery disease (CAD) in severe aortic stenosis (AS) is complex, especially with transcatheter aortic valve replacement (TAVR) availability.
- Outcomes of percutaneous coronary intervention (PCI) in patients with severe AS and CAD are not well-established.
- This study compares short-term PCI outcomes in patients with and without severe AS.
Purpose of the Study:
- To compare the short-term outcomes of PCI in patients with and without severe aortic stenosis.
- To identify risk factors for mortality following PCI in patients with severe AS.
Main Methods:
- Retrospective analysis of a PCI database from 1998-2008.
- Inclusion of 254 patients with severe AS and 508 propensity-matched patients without AS who underwent PCI.
- Primary endpoint: 30-day mortality post-PCI.
Main Results:
- 30-day mortality after PCI was similar between patients with and without severe AS (4.3% vs. 4.7%, P=0.2).
- Patients with severe AS and low ejection fraction (≤30%) had significantly higher 30-day mortality (5.4% vs. 1.2%, P<0.001).
- Patients with severe AS and high Society of Thoracic Surgeons (STS) score (≥10) also had higher 30-day mortality (10.4% vs. 0%, P<0.001).
Conclusions:
- PCI can be safely performed in patients with severe symptomatic AS and CAD, with no increased short-term mortality compared to controls.
- Low ejection fraction and high STS score are critical predictors of 30-day mortality post-PCI in severe AS patients.
- Findings guide management decisions for high-risk severe AS patients undergoing PCI, particularly those considered for TAVR.
Background:
With the availability of transcatheter aortic valve replacement, management of coronary artery disease in patients with severe aortic stenosis (AS) is posing challenges. Outcomes of percutaneous coronary intervention (PCI) in patients with severe AS and coronary artery disease remain unknown. We sought to compare the short-term outcomes of PCI in patients with and without AS.
Methods And Results:
From our PCI database, we identified 254 patients with severe AS who underwent PCI between 1998 and 2008. Using propensity matching, we found 508 patients without AS who underwent PCI in the same period. The primary end point of 30-day mortality after PCI was similar in patients with and without severe AS (4.3% [11 of 254] versus 4.7% [24 of 508]; hazard ratio, 0.93; 95% confidence interval, 0.51-1.69; P=0.2). Patients with low ejection fraction (≤30%) and severe AS had a higher 30-day post-PCI mortality compared with those with an ejection fraction >30% (5.4% [7 of 45] versus 1.2% [4 of 209]; P<0.001). In addition, AS patients with high Society of Thoracic Surgeons score (≥10) had a higher 30-day post-PCI mortality than those with a Society of Thoracic Surgeons score <10 (10.4% [10 of 96] versus 0%; P<0.001).
Conclusions:
PCI can be performed in patients with severe symptomatic AS and coronary artery disease without an increased risk of short-term mortality compared with propensity-matched patients without AS. Patients with ejection fraction ≤30% and Society of Thoracic Surgeons score ≥10% are at a highest risk of 30-day mortality after PCI. This finding has significant implications in the management of severe coronary artery disease in high-risk severe symptomatic AS patients being considered for transcatheter aortic valve replacement.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management
Acute Coronary Syndrome I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies

